Tag: RAMM Pharma Corp.
July 9, 2020
RAMM Pharma Announces Approval and Registration of Epifractán™ 5 Percent by Peru’s Ministry of Health and Enters Distribution Agreement to Supply Pharmacies in Peru
RAMM Pharma Corp. is pleased to announce that the Company’s Epifractán™ 5% formulation has been approved and registered by Peru’s... November 8, 2019
RAMM Pharma Corp. Commences Trading on the CSE Under Ticker Symbol “RAMM”
RAMM Pharma (CSE:RAMM) begins trading on the Canadian Securities Exchange today under the ticker symbol “RAMM”. October 30, 2019
RAMM Pharma Corp. Announces Closing of Business Combination with RAMM Pharma Holdings Corp., Medic Plast S.A. and Yurelan S.A.
RAMM Pharma Corp. is pleased to announce that on October 28, 2019 it completed its business combination with Medic Plast... October 29, 2019